报价延迟最少15分钟:2026/04/18 01:05 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.11 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.33/-1.20
|
|
企业价值
199.64M
|
| 资产负债 |
|
每股账面净值
2.89
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
7.15M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products. |
